Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Rang in Aktien #32282
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Aktienkurs
$0.01317984
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$10.52M
Veränderung (1 Tag)
-1.26%
Veränderung (1 Jahr)
-53.51%
Land
SE
Handel Spago Nanomedical AB (publ) (SPAGO)

Kategorie

Dividendenrendite-Verlauf für Spago Nanomedical AB (publ) (SPAGO)
Dividendenrendite (TTM) von Spago Nanomedical AB (publ) (Aktienkürzel: SPAGO) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Spago Nanomedical AB (publ) (SPAGO) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber